Gaithersburg, Md.
Novavax is expanding its operations in Gaithersburg, Md., with the long-term lease of 74,000 sf of manufacturing, lab, and office space in two buildings. The main facility will undergo renovation to become Novavax's primary commercial-scale plant for cGMP production of seasonal and pandemic VLP influenza vaccines. Completion is expected in mid-2012. The company's corporate headquarters will be relocated to the second building at the same campus.
